Browse Items (4 total)
- Tags: Disease-Free Survival
Can we approach zero relapse in breast cancer?
Tags: 2005, Adjuvant, Antineoplastic Agents, Aromatase Inhibitors/therapeutic use, Breast Neoplasms/mortality/pathology/*prevention & control/*therapy, Chemotherapy, Disease-Free Survival, Female, Gene Expression Profiling, Hormonal/*therapeutic use, Humans, Lymph Nodes/pathology, Mamounas Eleftherios P, Neoadjuvant Therapy, Prognosis, Recurrence, The oncologist
Generation of "virtual" control groups for single arm prostate cancer adjuvant trials.
Tags: *Nomograms, *Prostatectomy, 2014, Adjuvant/*methods, Aged, Ahlering Thomas, Antineoplastic Agents/therapeutic use, Carpenter Philip M, Chemotherapy, Chen Xin, Control Groups, Controlled Clinical Trials as Topic, Deng Mingsen, Disease-Free Survival, Gurley Michael J, Humans, Jia Zhenyu, Jiang Jun, Kattan Michael W, Koziol James A, Lee Chung, Lilly Michael B, Local/*drug therapy/mortality/pathology/surgery, Male, McClelland Michael, McLaren Christine E, Mercola Dan, Middle Aged, Neoplasm Recurrence, Pan Cong, PloS one, Prostate/drug effects/pathology/surgery, Prostatic Neoplasms/*drug therapy/mortality/pathology/surgery, Ruckle Herbert, Sawyers Anne, Skarecky Douglas, Sutton Manuel, Treatment Outcome, Wang Yipeng, Wang-Rodriguez Jessica, Xia Xiao-Qin, Zhu Jian-Guo
Regional Nodal Irradiation: Examining the Clinical Implications of Randomized Trials.
Tags: *Randomized Controlled Trials as Topic, 2016, Adjuvant/adverse effects/methods, American journal of clinical oncology, Arthur Douglas, Axilla, Breast Neoplasms/pathology/*radiotherapy, Disease-Free Survival, Female, Humans, Khan Atif, Lymph Nodes/*pathology, Lymphatic Irradiation/adverse effects/*methods, Lymphedema/etiology, Mantz Constantine, Mastectomy, Radiation Pneumonitis/etiology, Radiotherapy, Shah Chirag, Survival Rate, Verma Vivek, Vicini Frank, Wazer David
Phase II study of gefitinib in patients with advanced salivary gland cancers.
Tags: 2015, 80 and over, Adenocarcinoma/drug therapy/mortality/pathology, adenoid cystic carcinoma, Adenoid Cystic/*drug therapy/mortality/pathology, Adult, Aged, Antineoplastic Agents/*therapeutic use, Blumenschein George R Jr, Carcinoma, Department of Internal Medicine, Disease-Free Survival, Dose-Response Relationship, Drug, Drug Administration Schedule, El-Naggar Adel K, Female, Gefitinib, Glisson Bonnie S, Gonzalez-Angulo Ana M, Head & neck, Humans, Jakob John A, Kies Merrill S, Kupferman Michael E, Lee J Jack, Liu Diane D, Local/*drug therapy/mortality/pathology, Male, Maximum Tolerated Dose, Middle Aged, NEOMED College of Medicine, Neoplasm Invasiveness/pathology, Neoplasm Recurrence, Neoplasm Staging, non-adenoid cystic carcinoma, Prognosis, Quinazolines/*therapeutic use, Remission Induction, response to therapy, salivary gland cancer, Salivary Gland Neoplasms/*drug therapy/mortality/pathology, Survival Analysis, Treatment Outcome